S everal epidemiological studies have shown a relation between the human ABO blood group and coronary heart disease (CHD), such that individuals of a non-O type (A, B, or AB type) are more likely to have CHD than O-type individuals. 1-3 However, the mechanistic basis underlying this relationship requires further investigations.
of individuals (n=6476) undergoing diagnostic or interventional coronary angiography, we first verified the associations among ABO group, cholesterol levels, and CHD phenotypes and then performed mediation analyses in a model with cholesterol levels as a mediator for the effect of ABO group on CHD phenotypes.
Methods

Subjects
We studied 6476 consecutive patients undergoing diagnostic or interventional coronary angiography in the First Affiliated Hospital of Shantou University Medical College, the First Affiliated Hospital of Guangzhou Medical College, and the Second Affiliated Hospital of Guangzhou Medical College in Southern China. Data required for this study were collected from hospital records for the patients. All subjects were Chinese. The study was approved by the appropriate research ethics committee.
We collected demographic and clinical data including age, sex, ABO blood type, plasma levels of TC, LDLc, high-density lipoprotein cholesterol (HDLc) and triglycerides, coronary angiographic findings, prevalent or incident myocardial infarction (MI) diagnosed according to the World Health Organization criteria, systolic and diastolic blood pressure, and the presence or absence of diabetes mellitus. ABO blood typing and cholesterol and triglyceride measurements were conducted by the clinical chemistry department of the respective hospitals. Blood samples for cholesterol and triglyceride measurements were collected after overnight fasting.
The main demographic and clinical characteristics of the study subjects are summarized in Table 1 and in Table I in the Data Supplement. Of the 6476 subjects, 4518 had significant angiographically documented coronary artery disease (CAD) as having >50% diameter stenosis in ≥1 major epicardial coronary artery. A total of 2083 subjects had prevalent or incident MI.
Statistical Analysis
Values of TC, LDLc, HDLc, and triglycerides were logarithm transformed to normalize their distributions. Non-HDL cholesterol (NHDLc) values were calculated as TC minus HDLc and then normalized by logarithmic transformation. χ 2 test and logistic regression analysis were used to ascertain association of ABO blood types with CAD and MI, respectively, with adjustment for age, sex, and hospitals as covariates. t Test and general linear model analysis were used to examine differences in lipid levels between CAD and non-CAD groups, between MI and non-MI groups, and between O and non-O blood types, with adjustment for age, sex, and hospitals as covariates. The above analyses were then performed in male and female subjects separately, with age and hospitals as covariates. All P values were 2 sided.
For causal mediation analysis, the R package Mediation was used. 15 Briefly, the average causal mediation effect is estimated as the expected difference in the potential outcome (Y) when the mediator (M) takes the value that would realize under the treatment condition (T) as opposed to the control condition, while the treatment status is held constant, which is expressed in the following equation: δ(t)=E{Y(t,M(t1))-Y(t,M(t0))},where t, t1, t0 are specific values of T, with t1≠t0. Similarly, the average direct effect is defined as the expected difference in the potential outcome when the treatment is changed while the mediator is held constant at the value that would realize whether the treatment equals t, according to the following equation:ζ(t)=E{Y(t1,M(t))-Y(t0,M(t))}. The total effect of the treatment on the outcome is composed of the average causal mediation effect and the average direct effect. This model allows the mediation effect to be estimated for a variety of data types. 15 In this study, the blood type was regarded as the treatment variable in either a 2-group classification setting (A/B/AB versus O) or a 3-group classification setting (AB versus A/B versus O). The level of TC, LDLc, or NHDLc was regarded as the mediator. First, in the mediator model, a linear regression model was used to estimate the association between the treatment variable and the mediator. Second, in the outcome model, a generalized linear model was used to estimate the association of the mediator and the treatment variable and the outcome (either CAD or MI), using binomial probit link function. Finally, a nonparametric bootstrapping method with ≤100 000 simulations was applied to obtain accurate P values of the estimates of the total effects, direct effects, as well as mediation effects. The analyses were performed first in the sample as a whole with adjustment for age, sex, and hospitals and then separately in men and women with adjustment for age and hospitals. 
Results
We observed an association between non-O type (AB, A, or B) and the presence of significant CAD indicated by >50% stenosis in ≥1 coronary artery in angiography. The odds ratio (OR) for significant CAD was 1. Table 3 ), the reason for which is unknown. However, the levels of NHDLc, previously shown to be an independent and superior predictor of CHD from the Framingham Heart Study, 16 were higher in non-O-type than in O-type individuals (3.805 [0.020] mmol/L versus 3.669 [0.024]; P=3.1×10 −7 ; Table 3 ). There was no significant association between ABO group and triglycerides level ( Table 3) , which is consistent with findings from several other studies. [7] [8] [9] [10] [11] [12] The results were generally similar when men and women were analyzed separately ( Table IV in the  Data Supplement) .
As expected, levels of TC, LDLc, and NHDLc were higher in subjects with significant CAD than in those without and similarly were higher in the MI group as compared with the non-MI group (Table 4) , and these were also the case when men and women were analyzed separately (Table V in the Data Supplement). HDLc levels were lower in cases with significant CAD than in those without (Table 4) , with a similar trend in both sexes ( Table V in the Data  Supplement) , while no significant association was detected between HDLc and MI ( Table 4 and Table V in the Data Supplement). In the sample as a whole and in women, triglyceride level was higher in CAD cases but did not significantly differ between the MI and non-MI groups ( Table 4 and Table V in the Data Supplement). However, in men, it was lower in CAD and MI cases, the reason for which is unknown (Table V in the Data Supplement). Having detected that subjects of non-O type had higher ORs of significant CAD and MI as well as higher total TC, LDLc, and NHDLc levels, together with the observation that TC, LDLc, and NHDL levels were higher in subjects with significant CAD (than in those without) and in those with MI (than those without), we performed mediation analyses with TC, LDLc, and NHDLc as mediators for the associations of ABO group with CAD and MI. Mediation analysis assesses an intermediate variable as a mediator in the pathway between a risk factor and an outcome to estimate the extent to which the effect of the risk factor occurs through the mediator. [17] [18] [19] [20] This method has been used in various research fields including studies of effects of genetic variants. [21] [22] [23] [24] A mediation analysis in a model with CAD as the dependent variable, non-O versus O type as the independent variable, and LDLc level as the mediator variable, with age, sex, and hospitals as covariates, indicated that there was a 4.9% difference in CAD susceptibility between non-O type and O type (P=4.0×10 −5 ) and that 10% of this difference was mediated by increased LDLc level (0.5% of the difference in CAD susceptibility was mediated by LDLc level; P=7.8×10 −4 for mediation effect; Table 5 ). In the above model, substituting LDLc with TC or NHDLc as the mediator variable showed that TC and NHDLc had a similar mediation effect size to that of LDLc (Table 5 ). As expected, the levels of TC, LDLc, and NHDLc were highly correlated (correction coefficient, 0.873 for TC and LDLc; 0.890 for LDLc and NHDLc; and 0.959 for TC and NHDLc; all P<5×10 −20 ).
In a model with MI as the dependent variable, non-O versus O type as the independent variable, LDLc as the mediator variable, with age, sex, and hospitals as covariates, a mediation analysis estimated that there was 3.5% difference in MI Table 5 ). Substituting LDLc with TC or NHDLc as the mediator variable in this model showed that TC and NHDLc had a somewhat smaller mediation effect size (6% and 7%, respectively) than that of LDLc (Table 5 ).
In mediation analyses in which ABO group was coded as AB=2, A or B=1, and O=0, rather than non-O type=1 and O type=0 as in the models described above, the results were similar to those described above (Table 5) .
When the mediation analyses were performed in men and women separately, the mediation effect sizes of LDLc, TC, and NHDLc for CAD were similar; however, with regard to MI, mediation effects of LDLc, TC, and NHDLc were significant in men but not in women (Tables VI and VII in the  Data Supplement) .
Some limitations to our study warrant mentioning. First, the usefulness of the results of the mediation analyses will be dependent on the correctness of the presumed model. Second, there were no available data for ABO subtypes (such as A1 and A2) or single-nucleotide polymorphisms at the ABO locus for analysis in this study. However, the A2 allele is very rare in the Chinese, and therefore it is likely that type A in this study was mostly the A1 type. 25 Third, because this study was conducted in individuals of Chinese ancestry, the findings may not be generalizable to other races/ethnicities.
Discussion
In summary, our study confirms the presence of associations of ABO blood group with cholesterol levels and CHD susceptibility, with non-O types associating with higher TC, LDLc, and NHDLc levels and greater risks of significant CAD and MI in an investigation of a large group of individuals undergoing coronary angiography. In a presumed model with cholesterol levels as mediators for the associations of ABO group with CHD, our mediation analyses indicated that ≈10% of the effect of non-O type on CAD and MI susceptibility was attributable to the mediation of LDLc level and that this 10% was significantly nonzero. These findings provide a useful insight for understanding the genetic mechanisms underlying CHD susceptibility.
